In-vitro fertilization (IVF) Industry By Types of cycle (Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor), Donor Egg IVF Cycle) By Application (Fertility Clinics, Hospitals, Surgical Centers) - Global Size Analysis and Market Forecast 2019-2025

Global In-vitro fertilization (IVF) Industry was valued at USD 508 Million in the year 2017. Global In-vitro fertilization (IVF) Industry is further estimated to grow at a CAGR of 10.4 % from 2019 to reach USD 1121.51 Million by the year 2025. North America region holds the highest Industry share in 2017 and Europe is considered as the fastest growing Industry in the forecasted period. At country level, developed industries U.S holds a substantial Industry share in 2017 and it is projected to grow at a gradual pace in the coming years.

Major market players in In-Vitro Fertilization (IVF) Industry are OvaScience, EMD Serono Inc., Irvine Scientific, CooperSurgical Inc., Vitrolife AB, Cook Medical Inc., Progyny Inc., Genea Biomedx, Boston IVF, Kitazato Corp, and other brief information of 10 companies will be provided in report. Rising research and development expenses to address the changing demand of end users, similarly growth strategies such as acquisition, merger and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.

SWOT Analysis of IN-Vitro Fertilization (IVF) Industry:
Strength:
Declining fertility rate
Increasing incidences of male and female infertility
Weakness:
High Cost and Low Success Rate of the IVF Treatment
Lack of regulatory framework
Opportunities:
Availability of supportive government funding
Fertility Tourism
Threats:
Reducing Efficacy of Infertility Treatment with Advancing Age
Ethical considerations

The global in-vitro fertilization (IVF) Industry id segmented on the basis of types of cycle, by application and by region. On the basis of types of cycle the Industry is segmented as Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor) and Donor Egg IVF Cycle of which Fresh Cycle (Non-Donor) segment is expected to hold the highest Industry share during the forecast period.
On the basis of application the Industry is segmented as Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes, in which Fertility Clinics holds the highest Industry share.

In-Vitro Fertilization (IVF) Industry:
By Types of cycle
• Fresh Cycle (Non-Donor)
• Thawed IVF Cycle (Non-Donor)
• Donor Egg IVF Cycle

By Application
• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

By Region
• North America
o USA
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Rest of Europe
• APAC
o China
o India
o Japan
o Rest of Asia-Pacific
• RoW
o Latin America
o Middle East & Africa

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.